Shares of Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +0.37% inched 0.23% higher to $71.15 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.11% rising 0.23% to 4,468.73 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.21% rising 0.76% to 34,869.63. This was the stock's second consecutive day of gains. Gilead Sciences Inc. closed $2.19 below its 52-week high ($73.34), which the company reached on August 18th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.20% fell 0.70% to $165.80, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.02% fell 0.37% to $73.18, and AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.35% rose 0.75% to $107.48. Trading volume (11.0 M) eclipsed its 50-day average volume of 5.8 M.